Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Esophageal cAncer Screening Trial (EAST) Based on Novel Sponge Cytology：a Multicenter Nationwide Study

NCT04609813 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT04609813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04609813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Esophageal cAncer Screening Trial (EAST) Based on Novel Sponge Cytology：a Multicenter Nationwide Study
Lead sponsor
Changhai Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
June 30, 2022
Enrollment
14,597 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer, esophageal squamous cell carcinoma, gastroesophageal junction adenocarcinoma